A detailed history of Fmr LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Fmr LLC holds 4,445,268 shares of CDXS stock, worth $13.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,445,268
Previous 4,433,659 0.26%
Holding current value
$13.8 Million
Previous $15.5 Million 10.94%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.65 - $3.92 $30,763 - $45,507
11,609 Added 0.26%
4,445,268 $13.8 Million
Q1 2024

May 13, 2024

BUY
$2.59 - $4.65 $173,988 - $312,373
67,177 Added 1.54%
4,433,659 $15.5 Million
Q4 2023

Feb 13, 2024

BUY
$1.54 - $3.37 $47,589 - $104,139
30,902 Added 0.71%
4,366,482 $13.3 Million
Q3 2023

Nov 13, 2023

BUY
$1.5 - $3.75 $3.94 Million - $9.85 Million
2,626,400 Added 153.66%
4,335,580 $8.19 Million
Q2 2023

Aug 11, 2023

BUY
$2.21 - $4.43 $162,373 - $325,480
73,472 Added 4.49%
1,709,180 $4.79 Million
Q1 2023

May 11, 2023

SELL
$3.81 - $6.76 $93,828 - $166,478
-24,627 Reduced 1.48%
1,635,708 $6.77 Million
Q4 2022

Feb 13, 2023

SELL
$4.26 - $6.84 $707,253 - $1.14 Million
-166,022 Reduced 9.09%
1,660,335 $7.74 Million
Q3 2022

Nov 10, 2022

BUY
$6.06 - $12.86 $224,098 - $475,562
36,980 Added 2.07%
1,826,357 $11.1 Million
Q2 2022

Aug 12, 2022

BUY
$8.35 - $21.89 $3.39 Million - $8.88 Million
405,488 Added 29.3%
1,789,377 $18.7 Million
Q1 2022

May 13, 2022

BUY
$16.97 - $31.93 $59,394 - $111,755
3,500 Added 0.25%
1,383,889 $28.5 Million
Q4 2021

Feb 14, 2022

SELL
$25.61 - $41.78 $23,305 - $38,019
-910 Reduced 0.07%
1,380,389 $43.2 Million
Q3 2021

Nov 15, 2021

BUY
$19.65 - $27.99 $1.11 Million - $1.57 Million
56,258 Added 4.25%
1,381,299 $32.1 Million
Q2 2021

Aug 13, 2021

BUY
$17.48 - $25.46 $23.2 Million - $33.7 Million
1,325,041 New
1,325,041 $30 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $204M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.